Kempharm is looking at a possible resurgence in stock prices... The most recent news from the pharmaceutical company is positive, with a successful test of an ADHD prodrug. The current price looks like it is close to a fibbonaci level. If it breaks the downline and trends up, it would be a recovery from a strong downtrend, but the historical prices of this stock...
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
NASDAQ:KMPH
